OakChart

SI-BONE Inc

SIBNHealthcare·Medical Devices·USA·Small·NASD·Nov 11 • 3:59 PM ET

24.94-0.16 (-0.64%)
2026-11-12 00:10 CET
Market cap
1,132.34 USD m
Revenue, TTM
220.65 USD m
Net income, TTM
-13.69 USD m
Free cash flow, TTM
-4.19 USD m
EPS diluted, TTM
-0.31
P/E
-
Compare

Price

SIBN against its 20, 50 and 200-day averages
2050200beat
15.0020.0025.001.7M3.4MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26SIBNclose 24.9420-day 22.2550-day 20.18200-day 16.6824.9452w high52w low

3.8% under the 52-week high of 25.92 on 4 Nov 2026. 52-week low 11.48 on 11 May 2026. Last 15 sessions, 35.9% high to low

Volume 0.81× normal · the line is the 50-bar volume average

Profile

SIBN
52-week range, 93% of the way up
11.4825.92

SI-BONE, Inc. is a medical device company, which engages in the provision of a proprietary minimally invasive surgical implant system to fuse the sacroiliac joint for treatment of musculoskeletal disorders of the sacropelvic anatomy. It offers a proprietary minimally invasive surgical implant system, called iFuse, used to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in Santa Clara, CA.

IndexRUT
Employees376
IPOOct 17, 2018
Beta0.59
ATR, 14d1.24
Rel volume0.81
Short float10.55%
Insider own4.90%
Inst own106.78%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.13B
Enterprise Value1.02B
Income-13.69M
Sales220.65M
Book/sh4.10
Cash/sh3.24
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees376
IPOOct 17, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S5.10
P/B6.08
P/C7.69
P/FCF-
EV/EBITDA-
EV/Sales4.63
Quick Ratio6.15
Current Ratio7.58
Debt/Eq0.23
LT Debt/Eq0.23
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.31
EPS next Y-0.30
EPS next Q-0.07
EPS this Y22.98%
EPS next Y12.41%
EPS next 5Y27.08%
EPS past 3/5Y37.37% 21.79%
Sales past 3/5Y23.60% 22.32%
EPS Y/Y TTM39.54%
Sales Y/Y TTM13.99%
EPS Q/Q23.75%
Sales Q/Q14.49%
EarningsNov 02 AMC
EPS/Sales Surpr.36.71% 0.70%

Ownership

Insider Own4.90%
Insider Trans-16.87%
Inst Own106.78%
Inst Trans6.93%
ROA-5.58%
ROE-7.67%
ROIC-6.03%
Gross Margin79.40%
Oper. Margin-7.57%
Profit Margin-6.20%
SMA2012.10%
SMA5023.59%
SMA20049.52%
Trades-

Technical

Shs Outstand45.00M
Shs Float42.90M
Short Float10.55%
Short Ratio6.69
Short Interest4.53M
52W High25.92 -3.78%
52W Low11.48 117.25%
Volatility6.38% 5.69%
ATR (14)1.24
RSI (14)66.53
Beta0.59
Rel Volume0.81
Avg Volume676.34K
Volume547,025

Performance

Perf Week-0.04%
Perf Month26.73%
Perf Quarter31.61%
Perf Half Y76.13%
Perf YTD26.47%
Perf Year36.88%
Perf 3Y58.35%
Perf 5Y11.79%
Perf 10Y-
Recom1.00
Target Price26.78
Prev Close25.10
Price24.94
Change %-0.64%

Analyst ratings

latest 10 of 19
DateActionAnalystRating changeTargetImplied
Jul 28, 2026InitiatedUUBSBuy$24-3.8%
Jan 27, 2026InitiatedTTD CowenBuy$21-15.8%
Aug 06, 2024ReiteratedNNeedhamBuy$27 → $19-23.8%
Mar 28, 2024InitiatedPPiper SandlerOverweight$25+0.2%
Oct 12, 2022InitiatedJJefferiesBuy$20-19.8%
Apr 07, 2022ResumedCCantor FitzgeraldOverweight$34+36.3%
Jun 08, 2021InitiatedCCitigroupBuy$40+60.4%
Mar 09, 2021ReiteratedNNeedhamBuy$35 → $34+36.3%
Dec 16, 2020ReiteratedNNeedhamBuy$28 → $35+40.3%
Aug 04, 2020ReiteratedNNeedhamBuy$22 → $24-3.8%

Peers

Mkt cap
TickerCompanyMkt cap
ATECAlphatec Holdings Inc1.14B
GMEDGlobus Medical Inc9.99B
OFIXOrthofix Medical Inc292.66M
MDTMedtronic Plc129.98B
ENOVEnovis Corp1.65B
TMCITreace Medical Concepts Inc331.73M
KIDSOrthoPediatrics corp879.14M
SIShoulder Innovations Inc458.62M
SYKStryker Corp121.36B
ZBHZimmer Biomet Holdings Inc20.34B

Insider trading

latest 14 of 86
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
FRANCIS LAURAChief Executive OfficerNov 04 '26Sale25.3075,0001,897,642304,256Nov 06 05:02 PM
PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal OfrNov 04 '26Sale24.8036,241898,80240,167Nov 06 05:01 PM
Maheshwari AnshulChief Op & Financial OfficerNov 04 '26Sale25.003,24781,175211,250Nov 06 05:00 PM
DUNN JEFFREY WDirectorNov 02 '26Option Exercise4.6820,00093,60036,057Nov 04 04:54 PM
DUNN JEFFREY WDirectorNov 02 '26Sale20.8920,000417,82016,057Nov 04 04:54 PM
ANSHUL MAHESHWARIOfficerNov 04 '26Proposed Sale23.775,270125,268Nov 04 04:30 PM
MICHAEL PISETSKY SEPARATE PROPOfficerNov 04 '26Proposed Sale23.7736,241861,449Nov 04 04:23 PM
DAVID & LAURA FRANCIS JOINT REDirectorNov 04 '26Proposed Sale23.7775,0001,782,750Nov 04 04:21 PM
PISETSKY MICHAEL A.SVP, Ops & Adm/Chief Legal OfrOct 29 '26Sale22.1129,665655,745164,444Nov 02 05:19 PM
Maheshwari AnshulChief Op & Financial OfficerOct 29 '26Sale22.503,73884,105214,497Nov 02 05:17 PM
MICHAEL PISETSKY SEPARATE PROPOfficerOct 29 '26Proposed Sale21.8329,665647,587Oct 29 04:21 PM
ANSHUL MAHESHWARIOfficerOct 29 '26Proposed Sale21.833,73881,601Oct 29 04:17 PM
FRANCIS LAURAChief Executive OfficerOct 12 '26Sale20.0538,006762,013379,256Oct 14 05:10 PM
DAVID & LAURA FRANCIS JOINT REDirectorOct 12 '26Proposed Sale19.3738,006736,176Oct 13 08:19 AM

Held by

AUM
TickerCompanyAUM
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
IHIiShares U.S. Medical Devices ETFAUM: 4.07B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
IWCiShares Micro-Cap ETFAUM: 1.22B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-02-0.080-0.126-0.08055.7055.318
2026Q22026-08-03-0.090-0.150-0.09256.0155.349
2026Q12026-05-11-0.100-0.188-0.09952.5951.168
2025Q42026-02-23-0.040-0.126-0.03856.3555.4010
2025Q32025-11-10-0.110-0.166-0.10648.6646.659
2025Q22025-08-04-0.140-0.183-0.14448.6348.129
2025Q12025-05-05-0.150-0.226-0.15547.2945.139
2024Q42025-02-24-0.110-0.146-0.10749.0048.149
2024Q32024-11-12-0.160-0.239-0.15840.3440.499
2024Q22024-08-05-0.220-0.277-0.21639.9739.109
2024Q12024-05-06-0.270-0.309-0.26637.8736.499
2023Q42024-02-26-0.270-0.278-0.27138.8637.928
2023Q32023-11-06-0.250-0.342-0.24934.0132.388
2023Q22023-08-07-0.300-0.396-0.29633.3131.218
2023Q12023-05-01-0.320-0.413-0.31932.7129.178
2022Q42023-02-27-0.320-0.400-0.32331.9531.508

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-1.550-1.539-1.55467.3066.79
2020FY-1.500-1.527-1.50473.3973.35
2021FY-1.710-1.663-1.70790.1589.60
2022FY-1.790-1.870-1.791106.41105.83
2023FY-1.130-1.143-1.128138.89137.8
2024FY-0.750-0.784-0.746167.18166.15
2025FY-0.440-0.530-0.440200.93199.89
2026FY--0.339--232.14
2027FY--0.297--268.12
2028FY--0.171--308.62
2029FY--0.210--357.11
2030FY-0.320--400.1

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0390167.8467.5368.60
2026Q4S2026-11-0290068.2367.9068.60
2026Q4S2026-10-1890068.2367.9068.60
2026Q4S2026-10-1391068.2367.9068.60
2026Q4S2026-09-1191068.2367.9068.60
2026Q4S2026-08-0491068.2267.9068.60
2026Q4S2026-07-2790067.9066.6169.10
2026Q4S2026-07-2680068.0667.6469.10
2026Q4S2026-07-1583068.0667.6469.10
2026Q4S2026-05-1283068.0167.6169.10
2026Q4S2026-05-1080067.3866.2068.70
2026Q4S2026-02-2486067.3866.2068.70
2026Q4S2026-01-3070164.8363.4066.50
2026Q4S2026-01-2970164.8363.4066.50

Estimate history

EPS, annual-0.957-2.195-1.554-1.504-1.707-1.791-1.128-0.746-0.44-0.309
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.158-0.107-0.155-0.144-0.106-0.038-0.099-0.092-0.081
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual47.98355.3867.30173.38790.152106.409138.886167.178200.925220.65
Period201720182019202020212022202320242025TTM
Sales, quarterly40.3449.00247.2948.6348.65656.3552.58856.0155.704
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual24.07624.45125.16432.58333.67434.73240.69342.08643.64745.005
Period201720182019202020212022202320242025MRQ
Shares, quarterly41.7942.08642.4843.01443.27343.64744.20144.69745.005
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue220.65200.93167.18138.89106.4190.1573.3967.3055.38
Cost of Goods Sold Incl. D&A45.4641.0535.0629.4715.7110.438.906.794.83
Gross Profit175.19159.88132.12109.4290.7079.7264.4860.5150.55
Selling, General and Administrative Excl. Other191.90182.21167.37156.35150.31131.39103.0593.3162.51
Research and Development18.3417.4516.5615.0313.6312.449.467.285.38
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-16.71-22.33-35.25-46.93-59.61-51.67-38.57-32.80-11.96
Interest Expense2.432.633.443.462.823.526.104.955.11
Unusual Expense0.000.000.000.000.001.850.003.200.83
Net Income Before Taxes-13.69-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45
Income Taxes0.000.000.000.000.000.000.000.000.00
Consolidated Net Income-13.69-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45
Net Income From Continuing Operations-13.69-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45
Net Income-13.69-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45
EPS (Recurring)-0.30-0.44-0.75-1.13-1.79-1.67-1.50-1.46-2.12
EPS (Basic, Before Extraordinaries)-0.31-0.44-0.75-1.13-1.79-1.71-1.50-1.55-2.20
EPS (Diluted)-0.31-0.44-0.75-1.13-1.79-1.71-1.50-1.55-2.20
EBITDA-10.08-16.56-30.87-41.50-56.16-49.58-37.44-32.03-11.24
Non-Operating Income (Expense)5.456.057.787.061.170.460.972.550.45
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense23.6925.5225.8724.0623.0616.8711.937.462.31
Price To Sales Ratio3.834.223.485.814.378.1711.847.893.00
Gross Margin79.4079.5779.0378.7885.2488.4387.8789.9191.27
Operating Margin-7.57-11.11-21.08-33.79-56.02-57.31-52.55-48.74-21.61
Net Margin-6.20-9.41-18.49-31.20-57.57-62.75-59.54-57.06-31.51
Shares Outstanding45.0043.6542.0940.6934.7333.6732.5825.1624.45
Market Capitalization1,132.341,132.34587.97850.12469.15743.81967.59537.61508.38

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue55.7056.0152.5956.3548.6648.6347.2949.00
Cost of Goods Sold Incl. D&A11.5411.4610.6411.829.819.829.6010.22
Gross Profit44.1744.5541.9444.5338.8538.8137.7038.78
Selling, General and Administrative Excl. Other48.5249.3547.0446.9944.2345.8145.1744.27
Research and Development4.565.224.194.364.244.314.533.87
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-4.35-4.81-5.09-2.46-5.38-7.00-7.48-5.49
Interest Expense0.610.600.590.630.670.670.660.80
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-3.62-4.09-4.33-1.65-4.57-6.15-6.54-4.50
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-3.62-4.09-4.33-1.65-4.57-6.15-6.54-4.50
Net Income From Continuing Operations-3.62-4.09-4.33-1.65-4.57-6.15-6.54-4.50
Net Income-3.62-4.09-4.33-1.65-4.57-6.15-6.54-4.50
EPS (Recurring)-0.08-0.09-0.10-0.04-0.11-0.14-0.15-0.11
EPS (Basic, Before Extraordinaries)-0.08-0.09-0.10-0.04-0.11-0.14-0.15-0.11
EPS (Diluted)-0.08-0.09-0.10-0.04-0.11-0.14-0.15-0.11
EBITDA-2.66-3.13-3.48-0.82-3.90-5.64-6.20-4.28
Non-Operating Income (Expense)1.341.321.351.441.491.521.601.79
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense5.715.986.035.986.236.666.666.13
Price To Sales Ratio3.833.402.694.273.284.353.363.52
Gross Margin79.2979.5479.7679.0379.8479.8079.7179.13
Operating Margin-7.81-8.58-9.68-4.37-11.06-14.40-15.82-11.21
Net Margin-6.50-7.30-8.24-2.92-9.38-12.65-13.83-9.18
Shares Outstanding45.0044.7044.2043.6543.2743.0142.4842.09
Market Capitalization1,132.34723.78557.81855.68635.03802.00595.62587.97

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments147.82150.04166.0297.29146.98196.4391.78122.2222.41
Short Term Receivables30.4127.4621.9520.8714.2513.6111.728.497.42
Inventories33.9027.0720.2517.2811.505.635.453.342.55
Other Current Assets3.983.203.172.173.142.562.511.991.25
Total Current Assets216.12207.78211.39137.61175.87218.24111.46136.0433.63
Net Property, Plant & Equipment22.3922.3618.7119.5714.244.533.952.151.90
Total Investments and Advances0.000.000.000.000.000.001.280.000.00
Long-Term Note Receivable--------0.00
Intangible Assets--------0.04
Other Assets0.060.300.330.380.400.370.320.330.27
Total Assets238.56230.44230.43157.55190.51223.14117.01138.5235.83
Short Term Debt Incl. Current Port. of LT Debt0.941.151.421.391.340.004.360.000.00
Accounts Payable4.636.494.596.283.203.272.812.151.81
Income Tax Payable--------0.47
Other Current Liabilities19.7019.4917.4513.5112.3510.2011.616.865.26
Total Current Liabilities25.2827.1323.4621.1816.8913.4718.779.017.54
Long Term Debt35.7436.3337.5838.0439.1439.4534.8738.9638.70
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities0.000.010.020.030.060.850.360.360.42
Total Liabilities61.0263.4761.0559.2556.0953.7854.0048.3346.66
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00118.55
Common Equity177.53166.96169.3898.30134.42169.3663.0190.19-129.38
Total Shareholders Equity177.53166.96169.3898.30134.42169.3663.0190.19-10.83
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity177.53166.96169.3898.30134.42169.3663.0190.19-10.83
Total Liabilities & Stockholders Equity238.56230.44230.43157.55190.51223.14117.01138.5235.83
Book Value Per Share4.073.974.162.833.995.202.503.69-5.37
Tangible Book Value Per Share4.073.974.162.833.995.202.503.69-5.38
Full-Time Employees376349344357352295262183168
Price to Book Ratio6.123.554.884.555.565.758.595.66-3.57
Return on Assets-8.06-13.42-22.34-35.20-27.35-25.69-30.06-20.02-60.80
Return on Equity-10.97-18.38-32.38-52.64-37.25-37.61-50.13-43.98-
Return on Invested Capital-8.86-15.21-20.94-44.93-32.60-20.93-39.24-13.51-82.65
Quick Ratio7.216.668.155.689.7315.785.6514.734.12
Current Ratio8.557.669.016.5010.4116.205.9415.114.46

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-13.69-18.90-30.91-43.34-61.26-56.57-43.70-38.40-17.45
Depreciation6.635.774.385.433.452.091.130.770.72
Other Funds (Non Cash)23.3126.7824.2324.0323.7920.7114.436.483.23
Funds from Operations16.2613.65-2.31-13.88-34.01-33.78-28.14-31.15-13.50
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-10.17-14.32-10.12-4.83-7.64-5.76-2.53-0.48-1.02
Cash from Operating Activities6.08-0.67-12.43-18.71-41.66-39.53-30.66-31.63-14.52
Capital Expenditures-10.28-8.41-10.50-7.80-9.51-6.39-2.56-2.44-0.94
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00-
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00-
Purchase or Sale of Investments10.2512.5723.12-52.006.6957.97-60.3515.94-96.88
Purchase of Investments-169.88-192.53-205.38-189.50-119.51-102.02-179.17-143.86-96.88
Sale Or Maturity of Investments180.13205.10228.50137.50126.20159.99118.81159.800.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-0.024.1612.62-59.80-2.8151.58-62.9213.49-97.83
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock3.043.382.7290.252.204.91137.993.53115.15
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00-0.07
Sale of Common Pref Stock3.043.382.7290.252.204.91137.993.53115.22
Proceedsfrom Stock Options0.642.212.1585.861.822.34136.532.04113.61
Issuance or Reduction of Debt, Net0.000.00-0.770.690.00-6.62-0.750.000.00
Change in Long Term Debt0.000.00-0.770.690.00-6.62-0.750.000.00
Issuance of Long Term Debt0.000.0035.2335.960.0034.8944.550.000.00
Reduction of Long Term Debt0.000.00-36.00-35.270.00-41.51-45.300.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00-0.84-0.040.00
Other Financing Activities Uses0.000.000.000.000.000.00-0.84-0.040.00
Cash from Financing Activities3.043.381.9690.932.20-1.71136.403.49115.15
Exchange Rate Effect-0.270.43-0.480.13-0.43-0.500.32-0.04-0.09
Net Change in Cash8.827.291.6812.55-42.709.8443.15-14.692.71
Free Cash Flow-4.19-9.09-22.92-26.51-51.16-45.92-33.22-34.07-15.46
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments146.26145.94144.68147.82145.74145.54
Short Term Receivables32.2731.7831.5630.4127.0324.77
Inventories42.3538.3935.5333.9035.7334.24
Other Current Assets3.773.802.943.982.282.89
Total Current Assets224.65219.91214.72216.12210.78207.45
Net Property, Plant & Equipment31.9228.6327.7822.3923.1823.17
Total Investments and Advances0.000.000.000.000.000.00
Other Assets0.200.220.220.060.310.31
Total Assets256.77248.76242.72238.56234.27230.92
Short Term Debt Incl. Current Port. of LT Debt0.330.430.660.941.131.11
Accounts Payable10.508.546.764.637.727.50
Other Current Liabilities18.7915.0814.0719.7017.5916.15
Total Current Liabilities29.6224.0421.4925.2826.4424.75
Long Term Debt42.4742.3742.2935.7435.7035.83
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities72.0966.4163.7861.0262.1560.58
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity184.68182.35178.94177.53172.13170.34
Total Shareholders Equity184.68182.35178.94177.53172.13170.34
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity184.68182.35178.94177.53172.13170.34
Total Liabilities & Stockholders Equity256.77248.76242.72238.56234.27230.92
Book Value Per Share4.104.084.054.073.983.96
Tangible Book Value Per Share4.104.084.054.073.983.96
Full-Time Employees---376--
Price to Book Ratio6.124.033.114.963.724.78
Return on Assets-5.58-6.10-7.11-8.06-9.43-10.45
Return on Equity-7.67-8.30-9.65-10.98-12.91-14.18
Return on Invested Capital-1.59-1.82-1.96-0.77-2.20-2.98
Quick Ratio6.157.558.347.216.627.00
Current Ratio7.589.159.998.557.978.38

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-3.62-4.09-4.33-1.64-4.57-6.15
Depreciation1.691.681.621.641.491.37
Other Funds (Non Cash)5.405.796.305.836.987.43
Funds from Operations3.483.383.585.823.902.65
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.46-2.60-5.95-4.09-1.56-2.47
Cash from Operating Activities5.940.78-2.361.732.330.17
Capital Expenditures-6.37-1.54-1.08-1.29-2.96-2.10
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments2.29-1.19-5.1514.31-7.07-7.37
Purchase of Investments-41.71-42.19-51.28-34.69-59.07-51.47
Sale Or Maturity of Investments44.0041.0046.1349.0052.0044.10
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-4.08-2.74-6.2313.03-10.03-9.47
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.351.630.031.030.012.23
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.351.630.031.030.012.23
Proceedsfrom Stock Options0.000.000.000.640.001.57
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities0.351.630.031.030.012.23
Exchange Rate Effect-0.02-0.07-0.14-0.030.020.03
Net Change in Cash2.18-0.41-8.7115.75-7.66-7.04
Free Cash Flow-0.43-0.77-3.440.44-0.62-1.93

Revenue breakdown

Surgical & Medical Instruments & Apparatus2024: 167.18M 2025: 200.93M
Non-US2024: 8.76M 2025: 9.85M
United States2024: 158.42M 2025: 191.08M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3010.55%4.5M42.9M576.09K
2026-10-1511.04%4.7M42.6M542.78K
2026-09-3012.02%5.1M42.6M553.22K
2026-09-1513.90%5.9M42.6M570.32K
2026-08-3113.22%5.6M42.6M550.27K
2026-08-1412.58%5.3M42.4M549.61K
2026-07-3111.98%5.1M42.4M658.07K
2026-07-1513.12%5.5M42.0M666.58K
2026-06-3014.24%6.0M42.0M699.91K
2026-06-1514.12%5.9M42.0M682.58K
2026-05-2913.98%5.9M42.1M701.91K
2026-05-1513.56%5.7M42.1M729.73K
2026-04-3010.85%4.5M41.8M603.70K
2026-04-1511.06%4.6M41.9M605.19K
2026-03-319.28%3.9M41.8M585.37K
2026-03-138.62%3.6M41.8M540.14K
2026-02-276.87%2.9M41.8M538.40K
2026-02-136.44%2.7M41.8M537.00K
2026-01-306.27%2.4M38.8M589.21K
2026-01-156.69%2.6M38.8M552.49K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5020.3024.500.0023.8020.000.000.996-0.0190.000
call5.0017.8022.000.0013.0440.000.000.965-0.2260.003
call7.5015.3019.500.009.5680.000.000.940-0.2580.005
call10.0012.8017.000.007.4790.000.000.914-0.2650.006
call12.5010.3014.500.005.9800.000.000.885-0.2610.008
call15.007.8012.000.004.8010.000.000.853-0.2500.009
call17.505.309.500.003.8120.000.000.813-0.2320.010
call20.003.007.105.153.02330.000.000.759-0.2120.012
call22.500.654.702.732.2731,0000.000.679-0.1890.014
call25.000.100.901.000.59330.001.000.529-0.0940.015
call30.000.002.200.051.5951.000.000.269-0.1160.013
call35.000.002.150.002.3150.000.000.226-0.1520.012
put2.500.000.050.006.7070.000.00-0.004-0.0170.000
put5.000.002.150.0011.9620.000.00-0.036-0.2070.003
put7.500.002.150.009.2840.000.00-0.060-0.2410.005
put10.000.002.150.007.6080.000.00-0.087-0.2620.006
put12.500.002.150.006.0780.000.00-0.114-0.2560.008
put15.000.002.150.004.8870.000.00-0.147-0.2450.009
put17.500.002.150.103.6911.000.00-0.184-0.2130.010
put20.000.002.200.252.99510.000.00-0.242-0.2030.012
put22.500.002.400.002.3900.000.00-0.321-0.1870.014
put25.000.002.400.001.5410.000.00-0.471-0.0910.015
put30.003.706.600.001.9440.000.00-0.731-0.1130.013
put35.008.0012.200.003.2240.000.00-0.787-0.1400.011

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094/A2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-028-KCurrent report2026-11-02SEC
2026-10-29144Filing for proposed sale of securities under Rule 144.SEC
2026-10-29144Filing for proposed sale of securities under Rule 144.SEC
2026-10-144Statement of changes in beneficial ownership of securities2026-10-12SEC
2026-10-13144Filing for proposed sale of securities under Rule 144.SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-064Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-05144Filing for proposed sale of securities under Rule 144.SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-09-118-KCurrent report2026-08-21SEC
2026-09-034Statement of changes in beneficial ownership of securities2026-09-01SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-24144Filing for proposed sale of securities under Rule 144.SEC
2026-08-21144Filing for proposed sale of securities under Rule 144.SEC
2026-08-21144Filing for proposed sale of securities under Rule 144.SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-19SEC
2026-08-214Statement of changes in beneficial ownership of securities2026-08-20SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11003.30M4
2026-10002.02M7
2026-0900378.16K1
2026-08002.99M10
2026-0700108.00K2
2026-060054.51K1
2026-0500451.67K6
2026-040083.17K3
2026-030056.70K1
2026-02002.41M5
2026-0100668.26K4
2025-12001.16M4
2025-11002.17M12

Institutional holders

Manager% owned
First Light Asset Management, LLC18.33%
BlackRock, Inc.8.29%
CADIAN CAPITAL MANAGEMENT, LP7.55%
AMERICAN CENTURY COMPANIES INC5.66%
BROWN ADVISORY INC4.68%
Granahan Investment Management, LLC4.35%
VANGUARD CAPITAL MANAGEMENT LLC4.15%
Impax Asset Management Group plc3.18%
Nuveen, LLC2.95%
GILDER GAGNON HOWE & CO LLC2.83%

Funds

Fund% owned
Small Cap Growth Fund4.28%
Impax Small Cap Fund3.21%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
iShares Russell 2000 ETF2.57%
First Eagle Small Cap Opportunity Fund1.52%
College Retirement Equities Fund - Total Global Stock Account1.30%
JNL Multi-Manager Small Cap Growth Fund1.24%
Fidelity Small Cap Index Fund1.08%
VANGUARD EXTENDED MARKET INDEX FUND1.03%
iShares Russell 2000 Growth ETF0.91%

OakChart. SIBN. Cached 15 minutes.